Operating Expenses
Stock-based compensation expense
Thermo Fisher Scientific Stock-based compensation expense increased by 10.7% to $83.00M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2025
Last reportedQ1 2026May 1, 2026
How to read this metric
Higher levels indicate significant use of equity for compensation, which can lead to shareholder dilution over time.
Detailed definition
This represents the expense recognized for equity-based awards granted to employees, such as stock options or restricted...
Peer comparison
Standard operating expense for most public companies, particularly in competitive talent markets.
Metric ID:
ms_stock_based_compensationHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $75.00M | $83.00M |
| QoQ Change | — | +10.7% |
| YoY Change | — | +10.7% |
Range$75.00M – $83.00M
Avg YoY Growth+10.7%
Median YoY Growth+10.7%
Stock-based compensation expense at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's stock-based compensation expense?
- Thermo Fisher Scientific (TMO) reported stock-based compensation expense of $83.00M in Q1 2026.
- What does stock-based compensation expense mean?
- The cost of paying employees with company stock instead of cash.